A silk fibroin gel for injection and a preparation method and application thereof
Patent Information
- Application Number
- CN202611178816.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-08-05
- Publication Date
- 2026-10-09
AI Technical Summary
该工艺全程采用纯水体系,且其必须依赖固相膜布载体支撑成型,最终产物为固定式外用预制敷料,仅适用于创面修复场景,无法制备无载体、可流动、可注射的软组织填充凝胶
[0031]1、本发明采用无机盐溶液作为丝素蛋白的溶解介质,替代传统纯水配制体系,无需依赖纤维素膜布等固相载体支撑成型,突破了现有技术仅能制备固定式创面敷料的局限,所得凝胶体系具备良好推注性,可实现注射成型与软组织填充应用。同时,本发明在整个制备过程中不添加任何化学交联剂(如BDDE、二乙烯基砜等),完全避免了交联剂残留引发的生物毒性、过敏反应以及降解产物在体内累积的潜在安全风险。同时,也无需添加醇类等物理交联剂,消除了有机溶剂残留对生物安全性构成的隐患。所制备的丝素蛋白凝胶可直接用于体内注射填充,具有良好的生物相容性。
Smart Images

Figure CN122874645A_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of medical aesthetic filler materials, specifically to an injectable silk fibroin gel, its preparation method, and its application. Background Technology
[0002] Silk fibroin is a natural high-molecular-weight fibrous protein extracted from silkworm silk. Composed of eighteen amino acids including glycine, alanine, and serine, it possesses excellent biocompatibility, biodegradability, and superior mechanical properties. It has been approved by the U.S. Food and Drug Administration (FDA) as a biomaterial for clinical use. Silk fibroin can be processed into various forms such as solutions, hydrogels, scaffolds, and microspheres, showing broad application prospects in tissue engineering, wound repair, drug delivery, and soft tissue filling.
[0003] Hydrogels are one of the important application forms of silk fibroin. Currently, the methods for preparing silk fibroin hydrogels are mainly divided into two categories: physical cross-linking methods and chemical cross-linking methods.
[0004] Physical cross-linking methods typically utilize external physical fields or the addition of physical cross-linking agents to induce the formation of gels from silk fibroin. For example, Chinese invention patent CN101502670A discloses an ultrasonic-induced method for preparing silk fibroin hydrogels. This method uses ultrasonic oscillation to induce the silk fibroin solution to form a gel in a short time, but it is difficult to achieve injectability and in vivo formation. Another example is Chinese invention patent CN10686699A, which discloses a rapid preparation method for silk fibroin gels. This method uses a weak electric field to induce interactions between silk fibroin molecules, but the gel formed initially shows no significant conformational change, and its sol-gel transition is reversible. Furthermore, adding physical cross-linking agents such as alcohols (e.g., methanol, ethanol, isopropanol, polyethylene glycol) can accelerate the gelation of silk fibroin, but the residues of these additives pose a risk to biosafety, especially for implantable medical devices where residue control requirements are extremely stringent.
[0005] Chemical cross-linking involves forming a covalent cross-linked network between silk fibroin molecular chains using cross-linking agents (such as 1,4-butanediol diglycidyl ether (BDDE) and divinyl sulfone). For example, Chinese invention patents CN117771436A and CN119770740B both use BDDE as a cross-linking agent to prepare silk fibroin-hyaluronic acid composite gels. While chemical cross-linking can significantly improve the mechanical strength and stability of the gel, residual cross-linking agents may cause biotoxicity or allergic reactions, and the cumulative effect of cross-linking agent degradation products in vivo is unclear, posing potential safety risks. Chinese invention patent CN122057079A attempts to construct a chemically interpenetrating network using zero-length cross-linking agents (such as horseradish peroxidase and EDC) to avoid small molecule cross-linking agent residues, but its process is complex, requiring multiple steps such as tubular emulsification and crystallization induced by folding agents, and the final product is in the form of microspheres rather than a gel that can be directly injected.
[0006] Furthermore, the preparation of existing silk fibroin gels generally suffers from complex processes, long cycles, and harsh conditions. For example, Chinese invention patent CN106421902B obtains a rapidly gelled silk fibroin solution through low-temperature freeze-thaw treatment, but subsequent gelation still depends on temperature and time control, and the mechanical properties of the gel are limited. Chinese invention patent CN115282324B uses raw silk as raw material, prepares an aqueous solution of silk fibroin through lithium bromide dissolution and multiple rounds of dialysis, first pre-treats the aqueous solution of silk fibroin by shearing, then impregnates the sheared solution with a cellulose membrane carrier, and finally gels in situ on the surface of the membrane through long-term heat treatment to prepare a composite dressing. This process uses a pure water system throughout and must rely on a solid membrane carrier for support and shaping. The final product is a fixed pre-made external dressing, which is only suitable for wound repair scenarios and cannot prepare carrier-free, flowable, injectable soft tissue filling gels.
[0007] Therefore, there is an urgent need to develop a safe, efficient, and simple method for preparing silk fibroin gels, which can directly produce silk fibroin gels suitable for injection filling and with good mechanical properties without adding any cross-linking agents or requiring a solid-phase carrier, through a green and mild process route. Summary of the Invention
[0008] The purpose of this invention is to overcome the shortcomings of the prior art and provide a safe, efficient and simple method for preparing silk fibroin gel. Without adding any cross-linking agent or requiring a solid-phase carrier, a silk fibroin gel with good mechanical properties and fluidity suitable for injection filling can be directly obtained through a green and mild process route.
[0009] To achieve the above-mentioned objective, the present invention provides a method for preparing an injectable silk fibroin gel, characterized by comprising the following steps: Regenerated silk fibroin is dissolved in an inorganic salt solution to obtain a silk fibroin solution; the silk fibroin solution is then subjected to high-speed shearing and heat treatment in sequence to obtain a silk fibroin gel.
[0010] The preparation method does not add any crosslinking agent.
[0011] The molecular weight of the regenerated silk fibroin is 10kDa~300kDa.
[0012] The regenerated silk fibroin has a molecular weight of 10–200 kDa. Preferably, the regenerated silk fibroin has a molecular weight of 10–100 kDa.
[0013] The inorganic salt solution is selected from any one or a combination of phosphate buffer, carbonate buffer, acetate buffer, and sodium chloride solution; preferably, the inorganic salt solution is phosphate buffer or sodium chloride solution.
[0014] The phosphate buffer solution has a pH of 6.0 to 8.0 and a phosphate concentration of 0.02 to 0.2 mol / L. Preferably, the phosphate buffer solution has a pH of 6.5 to 7.8, for example, 7.0 or 7.4, and a phosphate concentration of 0.05 to 0.18 mol / L, for example, 0.12 mol / L or 0.15 mol / L.
[0015] The phosphate buffer solution includes sodium dihydrogen phosphate and / or disodium hydrogen phosphate.
[0016] The mass concentration of the sodium chloride solution is 0.02~0.2 mol / L. Preferably, the mass concentration of the sodium chloride solution is 0.05~0.18 mol / L, for example, 0.12 mol / L or 0.15 mol / L.
[0017] The mass concentration of regenerated silk fibroin in the silk fibroin solution is 0.5% to 20%. Preferably, the mass concentration of silk fibroin in the silk fibroin solution is 1.0% to 10%. More preferably, the mass concentration of silk fibroin in the silk fibroin solution is 2.0% to 5.0%, for example, 3.0% or 4.0%.
[0018] The high-speed shearing is performed using a shearing instrument, which is a high-shear disperser.
[0019] The high-speed shearing rotation speed is 5000~25000 r / min, preferably 7000~20000 r / min, for example 8000 r / min or 15000 r / min. The high-speed shearing time is 2 min~8 h, preferably 15 min~5 h, for example 40 min, 1 h, 2 h, 3 h, 4 h.
[0020] The heat treatment is performed using any one or more of the following methods: water bath, oven heat circulation, or oil bath. Preferably, the heat treatment is performed using a water bath or oven heat circulation.
[0021] The heat treatment temperature is 45–130°C. Preferably, the heat treatment temperature is 50–80°C, for example, 60°C or 70°C.
[0022] The heat treatment time is 2 to 72 hours. Preferably, the heat treatment time is 5 to 48 hours, for example, 8 hours, 12 hours, 18 hours, or 36 hours.
[0023] The present invention also provides an injectable silk fibroin gel, which is prepared by the preparation method described above.
[0024] The present invention also provides a silk fibroin composite filler, comprising the silk fibroin gel described above and a compound material; the compound material is selected from any one or more combinations of sodium hyaluronate, cross-linked sodium hyaluronate gel, collagen, recombinant collagen, sodium carboxymethyl cellulose, hydroxypropyl cellulose, physiological saline, and phosphate buffer.
[0025] The present invention also provides the application of silk fibroin gel or the above-mentioned silk fibroin composite filler in the preparation of filling products for correcting skin depressions.
[0026] The filler product is used for injectable filling of tear troughs, lips, forehead, neck, or hands.
[0027] The present invention also provides the application of silk fibroin gel or the above-mentioned silk fibroin composite filler in the preparation of tissue regeneration medical and cosmetic filler materials.
[0028] Based on common knowledge in the field, the above-mentioned preferred conditions can be combined arbitrarily to obtain various preferred embodiments of the present invention.
[0029] Unless otherwise stated, when this invention relates to percentages between liquids, the percentage is volume / volume percentage; when this invention relates to percentages between liquids and solids, the percentage is volume (ml) / weight (g) percentage; when this invention relates to percentages between solids and liquids, the percentage is weight (g) / volume (ml) percentage; the remainder is weight / weight percentage.
[0030] Compared with the prior art, the present invention has the following beneficial technical effects.
[0031] 1. This invention uses an inorganic salt solution as the dissolving medium for silk fibroin, replacing the traditional pure water preparation system. It eliminates the need for solid carriers such as cellulose membranes for molding, overcoming the limitation of existing technologies that can only prepare fixed wound dressings. The resulting gel system exhibits excellent injectability, enabling injection molding and soft tissue filling applications. Furthermore, this invention does not add any chemical cross-linking agents (such as BDDE, divinyl sulfone, etc.) during the entire preparation process, completely avoiding the potential safety risks of biotoxicity, allergic reactions, and the accumulation of degradation products in vivo caused by cross-linking agent residues. Simultaneously, it eliminates the need for physical cross-linking agents such as alcohols, thus removing the potential biosafety hazards posed by residual organic solvents. The prepared silk fibroin gel can be directly used for in vivo injection filling and exhibits excellent biocompatibility.
[0032] 2. This invention uses an inorganic salt solution as the dissolving medium for silk fibroin, resulting in a silk fibroin gel with an osmotic pressure of 200-400 mOsm / kg, which closely matches the osmotic pressure of human body fluids. This characteristic effectively reduces the risk of local tissue edema, cell damage, or inflammatory reactions caused by osmotic pressure differences after injection, thereby improving the tolerance and safety of the filler material in vivo.
[0033] 3. The preparation method of this invention requires only three steps: "dissolution-shearing-heating," eliminating the need for complex processes such as low-temperature freezing-thawing, ultrasonic oscillation, weak electric field induction, and tubular emulsification, and also requiring no additives. The preparation process is green and mild, with controllable conditions, simple operation, and suitable for large-scale industrial production.
[0034] 4. The silk fibroin solution prepared by the process of this invention forms a stable gel with uniform properties and no glue separation. Rheological testing shows that the silk fibroin gel of this invention has an elastic modulus (G') of over 5000 Pa at 1 Hz and a shear viscosity ≥ 50 Pa·s, exhibiting good viscoelasticity and support properties, which can meet the mechanical strength requirements of soft tissue filling.
[0035] 5. The silk fibroin gel prepared by this invention was tested with a 30G needle. The average pushing force was less than 15N, indicating good needle penetration. It is suitable for precise injection filling with a fine needle and can meet the filling needs of delicate areas such as tear troughs, lips, forehead, neck, and hands. Attached Figure Description
[0037] Figure 1 Photographs of the control standard in Comparative Example 1 and the silk fibroin gel prepared in Example 1; Figure 2 Photos of the silk fibroin gel prepared in Example 1 before and after sterilization; Figure 3 The results of viscoelasticity testing are for the silk fibroin gel prepared in Example 1; Figure 4 The shear viscosity test results are for the silk fibroin gel prepared in Example 1; Figure 5 The image shows the effect of filling animal skin with the silk fibroin gel prepared in Example 1. Detailed Implementation
[0038] The present invention is further illustrated below by way of embodiments, but the invention is not limited to the scope of the embodiments described herein. Experimental methods in the following embodiments that do not specify specific conditions were performed according to conventional methods and conditions, or as selected according to the product instructions.
[0039] The reagents and raw materials used in the following examples are all commercially available. The silk fibroin is a directly purchased soluble regenerated silk fibroin with a molecular weight of 10kDa to 100kDa.
[0040] Example 1
[0041] Prepare a phosphate buffer solution (pH=7.4, 0.12 mol / L based on phosphate concentration) using sodium dihydrogen phosphate monohydrate and disodium hydrogen phosphate dodecahydrate for later use; add 0.6 g of soluble regenerated silk fibroin to the phosphate buffer solution, mix well after complete dissolution to obtain a 2% silk fibroin solution.
[0042] The silk fibroin solution was sheared and dispersed using a high-shear disperser (IKA T25, Germany) at a speed of 20,000 rpm for 20 minutes. Then, it was heat-treated in an oven at 70°C for 24 hours to obtain a silk fibroin gel (before sterilization). The sample was then sterilized at 121°C for 15 minutes (after sterilization). The gel remained in good condition, with no glue-water separation observed.
[0043] Example 2
[0044] Prepare a phosphate buffer solution (pH=7.4, 0.12 mol / L based on phosphate concentration) using sodium dihydrogen phosphate monohydrate and disodium hydrogen phosphate dodecahydrate for later use; add 6.0 g of soluble regenerated silk fibroin to the phosphate buffer solution, dissolve completely and mix well to obtain a 2% silk fibroin solution.
[0045] The silk fibroin solution was sheared and dispersed using a high-shear disperser (IKA T25, Germany) at a speed of 10,000 rpm / min for 1 hour. Then, it was heat-treated in an oven at 70°C for 24 hours to obtain the silk fibroin gel.
[0046] Example 3
[0047] Prepare a phosphate buffer solution (pH=7.4, 0.15 mol / L based on phosphate concentration) using sodium dihydrogen phosphate monohydrate and disodium hydrogen phosphate dodecahydrate for later use; add 0.9 g of soluble regenerated silk fibroin to the phosphate buffer solution, mix thoroughly after complete dissolution to obtain a 3% silk fibroin solution.
[0048] The silk fibroin solution was sheared and dispersed using a high-shear disperser (IKA T25, Germany) at a speed of 20,000 rpm / min for 20 min. Then, it was heat-treated in a water bath at 60℃ for 48 h to obtain the silk fibroin gel.
[0049] Example 4
[0050] Prepare a phosphate buffer solution (pH=7.4, 0.12 mol / L based on phosphate concentration) using sodium dihydrogen phosphate monohydrate and disodium hydrogen phosphate dodecahydrate for later use; add 0.6 g of soluble regenerated silk fibroin to the phosphate buffer solution, mix well after complete dissolution to obtain a 2% silk fibroin solution.
[0051] The silk fibroin solution was sheared and dispersed using a high-shear disperser (IKA T25, Germany) at a speed of 8000 rpm / min for 1 hour. Then, it was heat-treated in a water bath at 70°C for 24 hours to obtain the silk fibroin gel.
[0052] Example 5
[0053] Prepare a sodium chloride solution (0.15 mol / L based on the mass concentration of sodium chloride) using sodium chloride and set aside. Add 0.6 g of soluble regenerated silk fibroin to the sodium chloride solution, and mix well after complete dissolution to obtain a silk fibroin solution with a mass concentration of 2%.
[0054] The silk fibroin solution was sheared and dispersed using a high-shear disperser (IKA T25, Germany) at a speed of 20,000 rpm / min for 40 min. Then, it was heat-treated in an oven at 70℃ for 24 h to obtain the silk fibroin gel.
[0055] Comparative Example 1
[0056] Prepare a phosphate buffer solution (pH=7.4, 0.12 mol / L based on phosphate concentration) using sodium dihydrogen phosphate monohydrate and disodium hydrogen phosphate dodecahydrate for later use; add 0.6 g of soluble regenerated silk fibroin to the phosphate buffer solution, dissolve completely and mix well to obtain a 2% silk fibroin solution.
[0057] The silk fibroin solution was directly heat-treated in an oven, omitting the shearing and dispersion step. The heat treatment temperature was controlled at 70℃ for 48 hours to obtain an ungelled silk fibroin solution (reference standard).
[0058] Comparative Example 2
[0059] Prepare a phosphate buffer solution (pH=7.4, 0.12 mol / L based on phosphate concentration) using sodium dihydrogen phosphate monohydrate and disodium hydrogen phosphate dodecahydrate for later use; add 0.6 g of soluble regenerated silk fibroin to the phosphate buffer solution, dissolve completely and mix well to obtain a 2% silk fibroin solution.
[0060] After standing at room temperature for 72 hours, an ungelled silk fibroin solution was obtained.
[0061] Performance testing
[0062] Appearance: This can visually demonstrate the changes in the properties of the gel. It can be observed and evaluated by rotating and inverting the gel. If the liquid does not flow when inverted, it has formed a gel.
[0063] Viscoelasticity: refers to the deformation and flow properties of the gel under test under external force. Specifically, it is tested using a rheometer in oscillation mode at a test temperature of 25℃, a starting frequency of 10Hz, an ending frequency of 0.1Hz, and the elastic modulus G' (Pa) and viscous modulus G'' (Pa) at 1Hz are observed.
[0064] Shear viscosity: Measured using a rheometer in scanning mode, with an initial shear rate of 0.1 s⁻¹. -1 End shear rate 1000s -1 Observation 1s -1 The shear viscosity (Pa.s) at the specified value.
[0065] Pushing force: The test was conducted using a universal testing machine. A 30G needle was used with the pre-filled syringe, and the pushing rate was set to 30mm / min. The pushing force was then measured.
[0066] Figure 1 The images show sample images of the control standard in Comparative Example 1 and the silk fibroin gel prepared in Example 1, from... Figure 1 The comparison results show that the control sample prepared in Comparative Example 1 is a free-flowing liquid and does not form a gel. In contrast, the silk fibroin gel prepared in Example 1 is a white to off-white gel with uniform properties and no glue separation.
[0067] Figure 2 The images show a comparison of the silk fibroin gel prepared in Example 1 before and after being sterilized by moist heat at 121°C for 15 minutes. Figure 2 It was found that the silk fibroin gel did not separate after moist heat sterilization. This indicates that the gel can withstand terminal sterilization, facilitating product storage and clinical application.
[0068] Figure 3 The viscoelasticity test results of the silk fibroin gel prepared in Example 1 are shown. Figure 3 It can be seen that at a frequency of 1 Hz, the elastic modulus G' is 12450 Pa and the viscoelastic modulus G'' is 1149 Pa, indicating that the silk fibroin gel prepared in Example 1 has good viscoelasticity. In contrast, the control sample prepared in Comparative Example 1, due to its lack of gelation, has very low viscoelasticity, with an elastic modulus G' < 100 Pa.
[0069] Figure 4 The shear viscosity test results of the silk fibroin gel prepared in Example 1 are shown. Figure 4 It can be seen that at a shear rate of 1s... -1 At this point, the shear viscosity is 140.6 Pa·s.
[0070] One sample of gel from Example 1 was taken and tested using a 30G needle. The average pushing force was 5.0N, indicating that the silk fibroin gel prepared in Example 1 is suitable for pushing and filling.
[0071] In addition, the test results for Examples 2, 3, and 5 are as follows: Example 2 12610 1743 198.1 3.9 Example 3 20280 1689 163.6 12.2 Example 5 14900 1359 263.0 4.2
[0072] The silk fibroin gels prepared in Examples 1, 2, 3, and 5 all have an elastic modulus G' greater than 10000 Pa, a shear viscosity greater than 100 Pa·s within the range of 12000~25000 Pa, and a shear viscosity greater than 100 Pa·s within the range of 150~300 Pa·s. They exhibit good viscoelasticity and support properties, and can meet the mechanical strength requirements of soft tissue filling.
[0073] Skin filling and degradation time test
[0074] The silk fibroin gel prepared in Example 1 was injected intradermally into guinea pigs for a filling experiment. Specifically, six guinea pigs were used as parallel controls. The injection method was as follows: 0.2 mL of the gel prepared in the above example was implanted into the skin on the back of each guinea pig. Adverse reactions such as redness, swelling, and subcutaneous nodules were observed for 7 days, and the degradation after implantation was monitored long-term. Figure 5 The following table shows the results of the experiment to illustrate the filling effect.
[0075] The reaction and degradation of the gel in Example 1 after injection Immediately after injection No redness, no nodules, no degradation 7 days No redness, no nodules, no degradation 15 days No redness or swelling, no nodules, partially degraded 30 days No redness or swelling, no nodules, partially degraded
[0076] As can be seen from the data in the table, the silk fibroin gel prepared in the embodiments of the present invention, when injected subcutaneously into guinea pigs, showed no obvious adverse reactions such as redness, swelling, or subcutaneous nodules. Its degradation time in skin tissue can be maintained for at least 30 days, demonstrating good biocompatibility and degradability, and thus having practical value for clinical application.
[0077] In summary, the outstanding feature of this invention is that it uses a direct dissolution method to prepare regenerated high-molecular-weight silk fibroin into a filler gel, which has a simple preparation process and good biocompatibility.
[0078] Finally, it should be noted that the terms “comprising,” “including,” or any other variations thereof in this application are intended to cover non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements includes not only those elements but also other elements not expressly listed, or elements inherent to such process, method, article, or apparatus.
[0079] Although this application has been disclosed above through the description of specific embodiments, it should be understood that those skilled in the art can devise various modifications, improvements, or equivalents to this application within the spirit and scope of the appended solutions. Such modifications, improvements, or equivalents should also be considered to be included within the scope of protection claimed in this application.
Claims
1. A method for preparing an injectable silk fibroin gel, characterized in that, Includes the following steps: Regenerated silk fibroin is dissolved in an inorganic salt solution to obtain a silk fibroin solution; the silk fibroin solution is subjected to high-speed shearing and heat treatment in sequence to obtain a silk fibroin gel; the preparation method does not add any cross-linking agent, and the molecular weight of the regenerated silk fibroin is 10kDa~300kDa.
2. The preparation method according to claim 1, characterized in that, The preparation method satisfies at least one of the following conditions a) to g): a) The molecular weight of the regenerated silk fibroin is 10kDa to 200kDa; b) The inorganic salt solution is selected from any one or a combination of phosphate buffer, carbonate buffer, acetate buffer, and sodium chloride solution; c) The mass concentration of regenerated silk fibroin in the silk fibroin solution is 0.5% to 20%; d) The high-speed shearing is performed using a shearing instrument, which is a high-shear disperser; e) The heat treatment is performed using any one or more of the following: water bath, oven heat circulation, or oil bath; f) The heat treatment temperature is 45–130°C; g) The heat treatment time is 2 to 72 hours.
3. The preparation method according to claim 2, characterized in that, The preparation method satisfies at least one of the following conditions a) to g): a) The molecular weight of the regenerated silk fibroin is 10–100 kDa; b) The inorganic salt solution is a phosphate buffer solution or a sodium chloride solution; c) The mass concentration of regenerated silk fibroin in the silk fibroin solution is 1.0% to 10%; d) The rotational speed of the high-speed shearing is 5000~25000 r / min; e) The heat treatment is carried out using a water bath or oven heat circulation; f) The heat treatment temperature is 50–80°C; g) The heat treatment time is 5 to 48 hours.
4. The preparation method according to claim 3, characterized in that, The preparation method satisfies at least one of the following conditions a) to d): a) The mass concentration of regenerated silk fibroin in the silk fibroin solution is 2.0% to 5.0%; b) The high-speed shearing time is 2 min to 8 h; c) The pH of the phosphate buffer solution is 6.0~8.0, and the phosphate concentration is 0.02~0.2 mol / L; d) The mass concentration of the sodium chloride solution is 0.02~0.2 mol / L.
5. The preparation method according to claim 4, characterized in that, The preparation method satisfies at least one of the following conditions a) to e): a) The rotational speed of the high-speed shear is 7000~20000 r / min; b) The high-speed shearing time is 15 min to 5 h; c) The pH of the phosphate buffer solution is 6.5-7.8, and the phosphate concentration is 0.05-0.18 mol / L; d) The phosphate buffer solution comprises sodium dihydrogen phosphate and / or disodium hydrogen phosphate; e) The mass concentration of the sodium chloride solution is 0.05~0.18 mol / L.
6. An injectable silk fibroin gel, characterized in that, The silk fibroin gel was prepared using the method described in any one of claims 1-5.
7. A silk fibroin composite filler, characterized in that, Includes the silk fibroin gel as described in claim 6 and the compound material; the compound material is selected from any one or more combinations of sodium hyaluronate, cross-linked sodium hyaluronate gel, collagen, recombinant collagen, sodium carboxymethyl cellulose, hydroxypropyl cellulose, physiological saline, and phosphate buffer.
8. The use of the silk fibroin gel according to claim 6 or the silk fibroin composite filler according to claim 7 in the preparation of filler products for correcting skin depressions.
9. The application according to claim 8, characterized in that, The filler product is used for injectable filling of tear troughs, periorbital area, lips, forehead, neck, or hands.
10. The application of the silk fibroin gel according to claim 6 or the silk fibroin composite filler according to claim 7 in the preparation of tissue regeneration medical aesthetic filler materials.
Citation Information
Patent Citations
Method for preparing silk fibroin hydrogel
CN101502670A
A rapid gelling silk fibroin solution and its preparation method
CN106421902B
A kind of silk fibroin hydrogel dressing and its preparation method and application
CN115282324B
Regenerated silk fibroin-sodium hyaluronate gel for injection and preparation method thereof
CN117771436A
A preparation method of silk fibroin-hyaluronic acid filler for injection
CN119770740B
